Amentoflavone, New Hope against SARS-CoV-2: An Outlook through its Scientific Records and an in silico Study
| Autor: | Rajib Hossain, Muhammad Torequl Islam, Pranta Ray, Divya Jain, Abu Saim Mohammad Saikat, Lutfun Nahar, Anupam Das Talukdar, Satyajit Sarker, Seyed Abdulmajid Ayatollahi, Miquel Martorell, Farzad Kobarfard, Natalia Cruz-Martins, Khattab Al-Khafaji, Anca Oana Docea, Daniela Calina, Javad Sharifi-Rad |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
Protease Coronavirus disease 2019 (COVID-19) viruses medicine.medical_treatment Viral pathogenesis In silico Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Protein Data Bank (RCSB PDB) Amentoflavone Biology Virology Transmembrane Protease Serine 2 chemistry.chemical_compound chemistry Drug Discovery medicine |
| Zdroj: | Pharmacognosy Research. 13:149-157 |
| ISSN: | 0974-8490 0976-4836 |
| DOI: | 10.5530/pres.13.3.7 |
| Popis: | Background: The plant-derived bioflavonoid amentoflavone has many important biological activities, among them remarkable antiviral effects, even against severe acute respiratory syndrome Coronavirus (SARS-CoV). It inhibits severe acute respiratory syndrome coronavirus (SARS-CoV) with an IC50 value of 8.3 M. (TMPRSS-2 activity is now thought to be the only factor necessary for cell entry and viral pathogenesis). In comparison, 3CLPRO is needed for COVID-19 replication and maturation during its life cycle. Aim: This study aims to perform an in silico study on amentoflavone activity against structural and non-structural severe acute respiratory syndrome coronavirus (SARS-CoV)-2 3-chymotrypsin-like protease (3CLPRO) and human transmembrane protease serine 2 (TMPRSS-2) proteins. Materials and Methods: Molecular docking studies were carried out using compounds against 3CLPRO and TMPRSS-2 proteins through the Swiss model, Uniport, PROCHECK, Swiss PDB viewer, PyMol, PyRx, and Desmond (Schrodinger package) computerized software. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|